Superworth

Zimmer Biomet PE ratio ZBH

Share price divided by earnings per share over the last twelve months, since 2010.

Today, Nov 2, 2026
23.7×
10-year median
31.2×
Against its 10-year history
33rd
percentile: 0 is its lowest day, 100 its highest
10-year range
11.2× to 126×
Peer median
24.3×

Zimmer Biomet's PE ratio is 23.7× as of Nov 2, 2026: a share price of $97.35 against $4.11 of earnings per share over the last twelve months.

That is below its ten-year median of 31.2×, lower than on 67% of days in the last ten years.

Over that time it ranged from 11.2× in Dec 2018 to 126× in Apr 2023.

The median for 9 medical device stocks of a similar size is 24.3×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far23.7×21.4×27.9×
202522.5×19.1×26.2×
202420.3×20.3×57.2×
202353.8×42.8×126×
202296.6×29.0×117×
202131.7×30.1×62.2×
202072.3×15.2×73.6×
201914.1×11.8×14.1×
201811.6×11.2×38.4×
201736.7×30.4×79.0×
201656.9×54.0×487×
201598.5×23.4×100×
201423.9×19.9×24.0×
201322.9×15.6×22.9×
201214.9×13.9×18.2×
201115.6×13.8×22.0×
201014.8×13.7×16.8×

Against its peers

Companies in Medical - Devices nearest Zimmer Biomet's size, closest first, today.

CompanyPE ratio
ZBHZimmer Biomet23.7×
DXCMDexCom33.6×
GEHCGE HealthCare Technologies18.3×
EWEdwards Lifesciences54.5×
BSXBoston Scientific17.6×
LIVNLivaNova23.7×
ITGRInteger42.5×
SYKStryker32.1×
MDTMedtronic24.3×
TMDXTransMedics17.4×
Peer median24.3×

Where Zimmer Biomet ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Zimmer Biomet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.